Intellect Design Arena (INTELLECT) near Rs 505: Is the 16% share-price crash justified when AI revenue is growing but profits are not?
Read More Pharma Industry News Scienture starts commercial rollout of Arbli, the first FDA-approved losartan oral suspension Find out how Scienture is changing the hypertension treatment market with the FDA-approved Arbli losartan oral suspension. bySoujanya RaviOctober 23, 2025